Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.
about
Late diagnosis: a factor associated with death from visceral leishmaniasis in elderly patients.Seronegative lyme neuroborreliosis in a patient using rituximab.Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis.FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis.Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases
P2860
Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Seronegative visceral leishman ...... following rituximab treatment.
@en
type
label
Seronegative visceral leishman ...... following rituximab treatment.
@en
prefLabel
Seronegative visceral leishman ...... following rituximab treatment.
@en
P2093
P2860
P1433
P1476
Seronegative visceral leishman ...... following rituximab treatment.
@en
P2093
A Casabianca
E Concialdi
E Ferroglio
M Marchetti
P2860
P2888
P304
P356
10.1007/S15010-011-0109-5
P577
2011-05-03T00:00:00Z
P6179
1007592250